Geron

Is It Time to Buy Geron?
Motley Fool
Sat, 06/14/14 - 09:23 am
Geron
Geron And The Mayo Clinic Working In Parallel To Release Clinical Hold Of Imetelstat
Seeking Alpha
Sat, 05/3/14 - 11:15 am
Geron
imetelstat
myelofibrosis
Geron says FDA halts patient enrollment in another cancer trial
Yahoo/Reuters
Thu, 03/20/14 - 09:08 am
FDA
Geron
imetelstat
myelofibrosis
Clinical Trial Hold Of Geron's Revolutionary Drug Imetelstat Will Be Temporary
Seeking Alpha
Tue, 03/18/14 - 10:47 am
imetelstat
Geron
clinical trials
myelofibrosis
Geron Plummets as FDA Halts Development of Blood Disorder Drug
Bloomberg
Wed, 03/12/14 - 10:03 am
FDA
Geron
imetelstat
myelofibrosis
Geron: A Biotech Stock With Potential For Long-Term Gains
Seeking Alpha
Sat, 02/22/14 - 10:43 am
Geron
This Week in Biotech: Let's Get Clinical!
Motley Fool
Sun, 02/2/14 - 11:30 am
AbbVie
Enanta Pharmaceuticals
ABT-450
hepatitis C
Medivation
Xtandi
prostate cancer
Astellas
Geron
imetelstat
PSMA-ADC
Progenics Pharmaceuticals
Idenix
Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin
Seeking Alpha
Tue, 01/28/14 - 11:19 am
Cellceutix
Brilacidin
Kevetrin
Cubist Pharmaceuticals
Epizyme
Geron
Geron Shares React to Imetelstat Mayo Study Update
TheStreet.com
Mon, 01/27/14 - 09:24 am
Geron
imetelstat
myelofibrosis
Piper Jaffray’s Seven Biotech Stocks to Buy With Huge Potential Upside
Wall St 24/7
Mon, 01/27/14 - 09:21 am
Avanir
BioDelivery Sciences
Conatus Pharmaceuticals
Geron
Halozyme
Neurocrine
Orexigen
Geron Corporation: The Best-Performing Biotechs of 2013
Motley Fool
Thu, 12/26/13 - 03:12 pm
Geron
Geron: Is Imetelstat The 'Aspirin' Of Cancer?
Seeking Alpha
Wed, 12/11/13 - 08:36 am
Geron
imetelstat
stem cells
cancer
Keep an Eye on Geron, Novartis, Cell Therapeutics, and Verastem Today
Motley Fool
Tue, 12/10/13 - 11:36 am
Verastem
Cell Therapeutics
Novartis
Geron
imetelstat
Jakavi
myelofibrosis
tosedostat
AML
VS-5584
Keep a Close Watch on Geron, Keryx, and Sangamo Today
Motley Fool
Fri, 12/6/13 - 10:21 am
Geron
Keryx
Sangamo BioSciences
Geron Soars After Study Shows Bone Marrow Drug’s Benefit
Bloomberg
Fri, 12/6/13 - 09:11 am
Geron
imetelstat
myelofibrosis
3 Innovative Biotech Companies Poised To Shine At TAP Partnership Conference
Seeking Alpha
Tue, 11/19/13 - 07:55 am
Geron
Cellceutix
Brilacidin
Cytori
This Week in Biotech
Motley Fool
Sun, 11/10/13 - 12:56 pm
Keryx
Geron
Arena
Eisai
Vivus
Curis
Immunogen
Geron's Promising News Poses No Threat To Incyte
Seeking Alpha
Fri, 11/8/13 - 11:59 am
Geron
Incyte
stem cells
imetelstat
3 Biotechs on the Move This Week
Motley Fool
Fri, 11/8/13 - 11:55 am
Immunogen
IMGN901
Immunomedics
Takeda
imetelstat
Geron
Geron soars after myelofibrosis drug shows 44% response rate
The Fly on the Wall
Thu, 11/7/13 - 09:45 am
myelofibrosis
Geron
imetelstat

Pages